ABANDONED – EXPRESS AFTER PUB
on 01 Jul 2005
Last Applicant/ Owned by
235 East 42nd Street
New York
NY
10017
Serial Number
78181702 filed on 05th Nov 2002
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EGIRIO
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, r Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, opthalmological preparations
Mark Details
Serial Number
No 78181702
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 040614
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Jul 2005 | ABANDONMENT - AFTER PUBLICATION |
| 01st Jul 2005 | TEAS EXPRESS ABANDONMENT RECEIVED |
| 01st Jun 2005 | ASSIGNED TO EXAMINER |
| 31st May 2005 | ASSIGNED TO EXAMINER |
| 21st Mar 2005 | ASSIGNED TO EXAMINER |
| 08th Mar 2005 | ASSIGNED TO EXAMINER |
| 07th Mar 2005 | ASSIGNED TO EXAMINER |
| 15th Feb 2005 | EXTENSION 3 GRANTED |
| 07th Feb 2005 | PAPER RECEIVED |
| 31st Jan 2005 | EXTENSION 3 FILED |